Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

ClinicalTrials.gov ID: NCT00572455

Public ClinicalTrials.gov record NCT00572455. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 2-STAGE, PHASE 2, DOUBLE-MASKED, RANDOMIZED, VEHICLE CONTROLLED, DOSE RESPONSE TRIAL OF PF-04217329 AND THE MARKETED FORMULATION OF LATANOPROST IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION

Study identification

NCT ID
NCT00572455
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
318 participants

Conditions and interventions

Interventions

  • PF-04217329 - Lowest Dose Drug
  • PF-04217329 - Low Dose Drug
  • PF-04217329 - Middle Dose Drug
  • PF-04217329 - High Middle Dose Drug
  • PF-04217329 - High Dose Drug
  • PF-4217329 - Highest Dose Drug
  • PF-04217329 - Vehicle Drug
  • Latanoprost Vehicle Drug
  • Latanoprost 0.005% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 10, 2007
Primary completion
Jun 25, 2009
Completion
Jun 25, 2009
Last update posted
Apr 29, 2021

2007 – 2009

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Sall Research Medical Center Artesia California 90701
Eye Research Foundation Newport Beach California 92663
North Bay Eye Associates, Inc. Petaluma California 94954
Centre For Health Care Poway California 92064
Atlantic Institute of Clinical Research Daytona Beach Florida 32114
Florida Health Care Plans Daytona Beach Florida 32114
Eye Associates of Fort Myers Fort Myers Florida 33901
International Eye Associates, PA Ormond Beach Florida 32174
Coastal Research Associates,LLC Atlanta Georgia 30339
Omni Eye Services of Atlanta Atlanta Georgia 30342
Eye Care Centers Management, Inc. Morrow Georgia 30260
The Eye Group of Southern Indiana Evansville Indiana 47710
Taustine Eye Center Louisville Kentucky 40217
Rochester Ophthalmological Group, PC Rochester New York 14618
Charlotte Eye Ear Nose and Throat Associates, PA Charlotte North Carolina 28210
Cornerstone Eye Care High Point North Carolina 27262
Mark J. Weiss, MD. Inc. Tulsa Oklahoma 74104
Glaucoma Care Center at Century Eye Care Bristol Pennsylvania 19007
Wills Eye Institute Philadelphia Pennsylvania 19107
Bluestein Custom Vision Charleston South Carolina 29414-5893
Total Eye Care, PA Memphis Tennessee 38119
Texan Eye Care, PA Austin Texas 78746
Eye Physicians of Austin Austin Texas 78756

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00572455, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2021 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00572455 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →